Sarepta Therapeutics, Inc.(SRPT)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
SRPT | 1.85 B | - | -34.30% | -6.93% | -$1.57 | -9.48% | 0.70x | 0.00% | $25.32 | $14.68 |
VRTX | 128.16 B | 29.67x | 12.50% | 35.00% | $17.04 | 23.54% | 9.77x | 0.00% | $560.25 | $400.74 |
ALNY | 30.03 B | 41.63x | 66.90% | 16.13% | $5.39 | 96.56% | 2.21x | 0.00% | $495.55 | $197.81 |
INSM | 22.22 B | - | 296.10% | -76.94% | -$4.06 | -87.22% | 0.98x | 0.00% | $212.75 | $90.39 |
CRSP | 5.06 B | - | 1041.40% | 0.00% | -$4.72 | -26.10% | 0.45x | 0.00% | $78.48 | $44.12 |
NTLA | 1.64 B | - | -46.20% | 0.00% | -$3.36 | -55.44% | 0.10x | 0.00% | $28.25 | $7.95 |
Peer Valuation & Performance Analysis
Peer group analysis for Sarepta Therapeutics, Inc. (SRPT) compared to its primary competitors (including VRTX, ALNY, INSM) reveals distinct metrics. SRPT trades at a valuation discount relative to its competitors, with a P/E ratio of -11.1x versus the peer average of 6.3x (representing a 276% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, SRPT's revenue growth of -34.3% lags behind the peer average of 274.1%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of -6.9% is comparable to the peer average of -5.2%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• SRPT ranks #0 in P/E ratio, #5 in revenue growth, and #4 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-07 | $17.28 | $17.67 | $16.98 | $17.50 | 2,872,800 | +1.10% |
| 2026-10-06 | $17.60 | $17.65 | $17.04 | $17.31 | 2,690,400 | -1.03% |
| 2026-10-05 | $17.39 | $17.55 | $17.10 | $17.49 | 2,198,100 | -0.06% |
| 2026-10-02 | $17.75 | $17.76 | $17.21 | $17.50 | 2,549,700 | -0.40% |
| 2026-10-01 | $18.14 | $18.25 | $17.52 | $17.57 | 2,884,300 | -3.57% |
| 2026-09-30 | $18.64 | $18.69 | $18.06 | $18.22 | 1,995,000 | -2.25% |
| 2026-09-29 | $18.68 | $18.74 | $18.38 | $18.64 | 1,368,600 | -0.85% |
| 2026-09-28 | $18.43 | $18.86 | $17.64 | $18.80 | 2,266,200 | +0.70% |
| 2026-09-25 | $18.49 | $18.77 | $18.02 | $18.67 | 2,218,600 | +1.52% |
| 2026-09-24 | $18.85 | $19.14 | $18.05 | $18.39 | 2,561,800 | -2.96% |
| 2026-09-23 | $20.72 | $20.76 | $18.74 | $18.95 | 3,757,100 | -8.94% |
| 2026-09-22 | $20.46 | $21.19 | $20.19 | $20.81 | 2,192,600 | +3.33% |
| 2026-09-21 | $20.29 | $20.50 | $19.97 | $20.14 | 1,756,500 | +0.15% |
| 2026-09-18 | $20.63 | $20.74 | $19.62 | $20.11 | 6,292,300 | -2.71% |
| 2026-09-17 | $20.23 | $21.75 | $19.97 | $20.67 | 2,588,000 | +4.61% |
Explore More Analysis for SRPT
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.